Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05092646 · ClinicalTrials.gov registry record · Phase 1
Evaluating Intra-articular Injection of Axolotl Ambient Compared to Saline in Subjects With Ankle Osteoarthritis
A Phase 1 study, sponsored by Axolotl Biologix.
- Terminated
- Registry status
- Phase 1
- Development phase
- 12
- Enrollment target
NCT05092646 is a Phase 1 study that was terminated before completion, run by Axolotl Biologix. The registered enrollment target is 12 participants.
The verdict
NCT05092646, a Phase 1 study, was terminated before completion, sponsored by Axolotl Biologix.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 12 participants
- Enrollment target
Study Summary
A Double-blind, Multi-Center, Prospective, Randomized Placebo-controlled Pilot Study Evaluating Intra-articular Injection of Axolotl Ambient Compared to Saline in Subjects with Ankle Osteoarthritis. The goal of this pilot study and subsequent pivotal trial is to evaluate the safety and effectiveness of Axolotl Ambient intra-articular injection for ameliorating the pain and dysfunction associated with ankle OA.
Interventions
- BIOLOGICAL Axolotl Ambient
- DRUG "Drug/Placebo: 0.9% Normal Saline"
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2021-12-01 |
| Est. Completion | 2023-11-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05092646
The ClinicalTrials.gov registry entry for NCT05092646 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Axolotl Biologix, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Axolotl Ambient is the first listed.
NCT05092646 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05092646 about?
NCT05092646 is a clinical study titled "Evaluating Intra-articular Injection of Axolotl Ambient Compared to Saline in Subjects With Ankle Osteoarthritis". A Double-blind, Multi-Center, Prospective, Randomized Placebo-controlled Pilot Study Evaluating Intra-articular Injection of Axolotl Ambient Compared to Saline in Subjects with Ankle Osteoarthritis. The goal of this pilot study and subsequent pivotal trial is to evaluate the safety and effectiveness...
What is the current status of trial NCT05092646?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 12 participants. The study started on 2021-12-01. Estimated completion is 2023-11-10.
What interventions are being tested in trial NCT05092646?
The interventions under investigation include: Axolotl Ambient (BIOLOGICAL), "Drug/Placebo: 0.9% Normal Saline" (DRUG).
Who is sponsoring clinical trial NCT05092646?
This trial is sponsored by Axolotl Biologix, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.